Clinical Trials Logo

Filter by:
NCT ID: NCT05084131 Completed - Colorectal Surgery Clinical Trials

Web-based Visit for Colorectal Surgery

Web-visit
Start date: May 14, 2019
Phase:
Study type: Observational

The purpose of this study to evaluate how well an online format would work for the first post-operative visit after a patient undergoes colon and rectal surgery. This online format is integrated into Epic MyChart. This study aims to determine whether the online format is feasible and acceptable to patients and surgeons as a standard post-operative visit.

NCT ID: NCT05084105 Completed - Cannabis Use Clinical Trials

Cannabis and Aging

Start date: February 1, 2020
Phase:
Study type: Observational

With increased availability and use of cannabis by older adults aged ≥ 50 years, a rigorous evaluation of the benefits and risks of cannabis use in these individuals is necessary. Our proposed project will investigate whether older adults who initiate cannabis use after the age of 50 are at an increased risk of fall and what are the underlying mechanisms. We will measure motor and cognitive function in older cannabis users and nonusers and we will use positron emission tomography to determine brain activity and how it is associated with fall risk.

NCT ID: NCT05083585 Completed - Clinical trials for Respiratory Syncytial Virus Prevention

A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years Old

Start date: October 8, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority in terms of humoral immune responses induced by vaccination with one dose of the Phase 3 clinical trial material (CTM) compared with one dose of the Phase 2b CTM.

NCT ID: NCT05083559 Completed - Type 1 Diabetes Clinical Trials

Two Way Crossover Closed Loop Study R-AP vs MPC

Start date: December 8, 2021
Phase: N/A
Study type: Interventional

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. The robust R-AP system used in this protocol has been designed to handle a variety of real-world scenarios that are critical to a high-risk patient population. The investigators will test how well the new algorithm handles missed or inaccurate meal announcements. This type of algorithm may significantly improve glucose control over the standard model predictive control (MPC) closed-loop algorithm without these new algorithm features for patients with type 1 diabetes.

NCT ID: NCT05083455 Completed - Clinical trials for Deep Vein Thrombosis, Pulmonary Embolus

Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data

Start date: September 22, 2020
Phase:
Study type: Observational

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

NCT ID: NCT05083429 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Replication of the POET-COPD Trial in Healthcare Claims Data

Start date: September 22, 2020
Phase:
Study type: Observational

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

NCT ID: NCT05083351 Completed - Healthy Clinical Trials

Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation

Start date: October 13, 2021
Phase: N/A
Study type: Interventional

Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and skin pigmentation.

NCT ID: NCT05083338 Completed - Clinical trials for Malignant Solid Neoplasm

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

Start date: August 10, 2021
Phase:
Study type: Observational

This study learns if depression, anxiety, and catastrophizing (thought patterns that prompt people to expect the worst) are associated with chronic pain after surgery among patients who are scheduled to have cytoreductive surgery with intraoperative hyperthermic chemotherapy. Information from this study may improve the understanding of persistent and chronic postsurgical pain integrating multiple layers of biological and behavioral sciences.

NCT ID: NCT05083312 Completed - Clinical trials for Eosinophilic Esophagitis

Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial

FLUTEEN
Start date: September 30, 2021
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled study of APT-1011, followed by an open-label extension (OLE) in adolescents (≥12 to <18 years) with EoE.

NCT ID: NCT05083260 Completed - Parkinson Disease Clinical Trials

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

Start date: January 4, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

A 28-day phase 2a, double-blind, placebo-controlled (1:1), multi-center study of 20 mg NE3107, twice daily of safety, potential drug-drug interactions, and MDS-UPDRS defined activity in patients with Parkinson's disease . Study will enroll 40 patients that are currently taking immediate release levodopa/ carbidopa (IRLC) and have a practically defined early morning off-state for IRLC. Day one- baseline UPDRS and IRLC PK sampling; day 2- start NE3107 dosing, assess UPDRS during onset and NE3107 PK sampling, rescue meds as needed after 4 hours; day 3 and 14- NE3107 + IRLC UPDRS assessment and PK sampling; day 28- NE3107 + IRLC UPDRS assessments. Optional overnight stays in clinic prior to Day 1-3, 14, and 28.